Delivery Order SPE2DB20D3103-SPE2DB23FP7R0

Award Date 9/18/23
Potential Completion Date 9/19/23
Potential Value $4.1K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of Wegovy 2.4 mg/0.75 ml pens, a pharmaceutical product, to the Medical Supply Chain division of the Defense Logistics Agency (DLA). The contract has a ceiling value of $14,417.89 and an ultimate completion date of May 10, 2024. The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The contract is a delivery order under an Indefinite Delivery Contract (IDC) valued at up to...
This federal contract award is for the delivery of Wegovy 1 mg/0.5 ml pens to the Defense Logistics Agency (DLA), a component of the Department of Defense. The $4,203.15 delivery order was awarded to AmerisourceBergen Drug Corp, a subsidiary of the parent company Cencora, Inc. This contract does not have a set-aside designation, indicating it was awarded through full and open competition. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award is for the delivery of Wegovy 2.4 mg/0.75 ml pens to the Defense Logistics Agency (DLA), a defense agency under the Department of Defense (DoD). The contract, valued at $1,062.22, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, as a delivery order under the company's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical. This IDC, valued at up to $999,999,999.00 and running through December 2025, serves as the...
This federal contract award is for the delivery of Wegovy 0.5 mg/0.5 ml pens to the Defense Logistics Agency (DLA). The contract, valued at $1,188.76, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a firm fixed price and an ultimate completion date of May 25, 2023. It is a delivery order contract, not associated with a specific set-aside requirement. Amerisourcebergen Drug Corp holds a larger Indefinite...
This federal contract award is for the delivery of Wegovy 0.25 mg/0.5 ml pens to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract has a ceiling value of $8,678.37 and is a delivery order contract with a firm fixed price pricing type. The contract has a period of performance through June 9, 2023. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp holds a...
This federal contract award is for the delivery of Wegovy 2.4 mg/0.75 ml pens to the U.S. Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $30,887.36, was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract has a completion date of February 22, 2024 and is a firm fixed-price delivery order. There is no set-aside designation for this award. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that serves...
This federal contract award, valued at $5,549.53, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Wegovy 2.4 mg/0.75 ml pen 0.75 ml, a pharmaceutical product, with a final completion date of December 7, 2023. The award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support...
This federal contract award is for the delivery of Wegovy 1.7 mg/0.75 ml pens with a 0.75 ml dosage. The contract was awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $4,462.01 and an ultimate completion date of December 10, 2024. It is a firm-fixed-price delivery order contract, with no set-aside designation. AmerisourceBergen Drug Corp holds a significant...
The Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Wegovy 1 mg/0.5 ml pens. The $1,645.62 firm fixed-price contract has a completion date of September 26, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical...
The federal contract award is for the delivery of Wegovy 1.7 mg/0.75 ml pens to the Defense Logistics Agency (DLA). The $3,576.30 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This award is a child contract under a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical program, which covers a comprehensive range of pharmaceutical...
  • SPE2DB20D3103
    Indefinite Delivery Contract
  • SPE2DB20D3103-SPE2DB23FP7R0
    Delivery Order

This federal contract award is for the delivery of Wegovy 2.4 mg/0.75 ml pens, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract, valued at $4,116.15, was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Cencora, Inc. holds with the DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to support military and veteran healthcare programs. The contract does not have a set-aside designation, indicating it was awarded through full and open competition.

Generated 2/27/25, 12:32 PM